Impacts of time-of-day of nivolumab infusion on treatment efficacy for patients with head and neck squamous cell carcinoma

被引：0
|
作者：
Tsunoki, T. [1 ]
Kadowaki, S. [2 ]
Mizuno, T. [2 ]
Ishizuka, Y. [2 ]
Sakakida, T. [2 ]
Narita, Y. [2 ]
Honda, K. [2 ]
Masuishi, T. [2 ]
Taniguchi, H. [2 ]
Ando, M. [2 ]
Muro, K. [2 ]
Hanai, N. [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Head & Neck Surg, Nagoya, Japan
[2] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.436
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
413MO
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy of Nivolumab and Pembrolizumab in Platinum-sensitive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Yamashita, G. A., I
    Okamoto, I. S. A. K. U.
    Ito, T. A. T. S. U. Y. A.
    Tokashiki, K. U. N. I. H. I. K. O.
    Okada, T. A. K. U. R. O.
    Tsukahara, K. I. Y. O. A. K. I.
    ANTICANCER RESEARCH, 2023, 43 (08) : 3679 - 3683
  • [22] Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma
    Maseki, Shinichiro
    Ijichi, Kei
    Nakanishi, Hayao
    Hasegawa, Yasuhisa
    Ogawa, Tetsuya
    Murakami, Shingo
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (05) : 918 - 924
  • [23] Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a national DAHANCA cohort study
    Soby, Sebastian
    Gothelf, Anita
    Gyldenkerne, Niels
    Bentzen, Jens
    Nowicka-Matus, Kinga
    Tramm, Trine
    Eriksen, Jesper Grau
    ACTA ONCOLOGICA, 2022, 61 (08) : 972 - 978
  • [24] Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
    Hanna, Glenn J.
    O'Neill, Anne
    Shin, Kee-Young
    Wong, Kristine
    Jo, Vickie Y.
    Quinn, Charles T.
    Cutler, Jennifer M.
    Flynn, Michelle
    Lizotte, Patrick H.
    Annino, Donald J., Jr.
    Goguen, Laura A.
    Kass, Jason, I
    Rettig, Eleni M.
    Sethi, Rosh K., V
    Lorch, Jochen H.
    Schoenfeld, Jonathan D.
    Margalit, Danielle N.
    Tishler, Roy B.
    Everett, Peter C.
    Desai, Anupam M.
    Cavanaugh, Megan E.
    Paweletz, Cloud P.
    Egloff, Ann Marie
    Uppaluri, Ravindra
    Haddad, Robert, I
    CLINICAL CANCER RESEARCH, 2022, 28 (03) : 468 - 478
  • [25] Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany
    Singh, Prianka
    McDonald, Laura
    Waldenberger, Daniela
    Welslau, Manfred
    von der Heyde, Eyck
    Gauler, Thomas
    Dietz, Andreas
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (11): : 3540 - 3551
  • [26] IMPACT OF IMMUNOTHERAPY TIME-OF-DAY INFUSION ON OVERALL SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Patel, Jimmy
    Draper, Amber
    Woo, Yena
    Dhabaan, Layla
    Patel, Pretesh
    Jani, Ashesh
    Carthon, Bradley
    Master, Viraj
    Kissick, Haydn
    Bilen, Mehmet
    Buchwald, Zachary
    Qian, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A886 - A886
  • [27] Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
    Hoell, Pascale Alicia
    Elsayad, Khaled
    Berssenbruegge, Hendrik
    Hering, Dominik
    Kittel, Christopher
    Kleinheinz, Johannes
    Bleckmann, Annalen
    Evers, Georg
    Wardelmann, Eva
    Rudack, Claudia
    Eich, Hans Theodor
    ANTICANCER RESEARCH, 2023, 43 (03) : 1255 - 1263
  • [28] Association of immune-related adverse events and efficacy in Japanese patients with squamous cell carcinoma of the head and neck treated with nivolumab
    Otsuka, T.
    Fujiishi, K.
    Matsumoto, K.
    Kimura, T.
    Koike, R.
    Cho, H.
    Hasegawa, A.
    Nishio, M.
    Otozai, S.
    Yoshii, T.
    Kudo, T.
    Fujisawa, F.
    Sugimoto, N.
    Yagi, T.
    Imamura, F.
    Fujii, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [29] Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Wada, Akihisa
    Enokida, Tomohiro
    Okano, Susumu
    Sato, Masanobu
    Tanaka, Hideki
    Ueda, Yuri
    Fujisawa, Takao
    Takeshita, Naohiro
    Tanaka, Nobukazu
    Tahara, Makoto
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 30 - 38
  • [30] Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
    Ferris, Robert L.
    Licitra, Lisa
    Fayette, Jerome
    Even, Caroline
    Blumenschein, George, Jr.
    Harrington, Kevin J.
    Guigay, Joel
    Vokes, Everett E.
    Saba, Nabil F.
    Haddad, Robert
    Ramkumar, Shanmugasundaram
    Russell, Jeffery
    Brossart, Peter
    Tahara, Makoto
    Colevas, A. Dimitrios
    Concha-Benavente, Fernando
    Lynch, Mark
    Li, Li
    Gillison, Maura L.
    CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5221 - 5230
12345